Patent foramen ovale (PFO) closure reduced the risk for recurrent ischemic stroke in most young and middle-aged adults with cryptogenic stroke but increased the risk for atrial fibrillation (AF) in a ...
The US Food and Drug Administration (FDA) on Friday approved Minnesota-based St. Jude Medical’s Amplatzer PFO Occluder, which is intended to reduce the risk of a stroke for some patients who ...
Successfully identified PFOs in 30 patients across the Netherlands and UK FOQUS scans the whole brain for emboli in 40 seconds and can be performed in physician offices or diagnostic centers Using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results